
Delighted to host the first annual @VasuLabUCSF holiday party - grateful to work with these people every day.

Cancer signaling, (single cell) genomics, and functional genetics, with an emphasis on better diagnostic tests and treatments for neurofibromatosis.

Delighted to host the first annual @VasuLabUCSF holiday party - grateful to work with these people every day.

It's official — the Vasudevan Lab received its first @NIH_NCI R01 to study neurofibromatosis tumor suppressors in nerve sheath tumors! Grateful to @UCSFRadOnc @NeurosurgUCSF @UCSFCancer @ChildrensTumor @ntapresearch @GilbertFamilyFd. It takes a village.

Exciting new paper by @VasuLabUCSF et al! "IFN signaling is associated with radiotherapy response in malignant peripheral nerve sheath tumors" jci.org/articles/view/195652 @NeurosurgUCSF @UCSFHospitals
This study is directly relevant to the clinical care of patients with the most common malignant tumor of the peripheral nervous system, while providing fundamental biological insight👇 Harish N. Vasudevan @VasuLabUCSF & team @UCSF reveal transcriptional, functional genetic, and cellular mechanisms of interferon signaling that underlie radiotherapy response in people with #MPNST: doi.org/10.1172/JCI195652

This study is directly relevant to the clinical care of patients with the most common malignant tumor of the peripheral nervous system, while providing fundamental biological insight👇 Harish N. Vasudevan @VasuLabUCSF & team @UCSF reveal transcriptional, functional genetic, and cellular mechanisms of interferon signaling that underlie radiotherapy response in people with #MPNST: doi.org/10.1172/JCI195652

NF1 is frequently mutated in #glioblastoma, yet therapies targeting this alteration often fall short. @VasuLabUCSF & team @UCSF now show NF1 mutant glioblastomas exhibit prognostic signatures with distinct sensitivity to MEK inhibition: insight.jci.org/articles/vie…

Excellent time giving grand rounds last week @UMRogelCancer with old friends @gouthamnarla and new ones @castro2355_mg @UCSFCancer @NeurosurgUCSF

Happy 4th of July - to celebrate, we asked if there is meaningful heterogeneity within somatic NF1 mutant glioblastomas? We think so biorxiv.org/content/10.1101/… As always, appreciate everyone that made this work possible @NeurosurgUCSF @UCSFCancer @ntapresearch @ChildrensTumor

A delightful time catching up with 10 of NTAP’s 18 Francis S. Collins Scholars & their mentors while in Brussels @ChildrensTumor. Thank you all for your dedication to moving the needle in NF1 research! #NFCON24 #endNF

Sunrise-ish run through brussels - enjoying every part of the annual @ChildrensTumor meeting #nfcon24 with friends from @NeurosurgUCSF @ntapresearch

Excited that our DoD New Investigator Award (cdmrp.health.mil/nfrp/awards…) is officially funded - thanks to everyone that helped make this happen @CDMRP @domespo @simanshu and time to get to work!

A pleasure to review the therapeutic landscape for NF-1 with my future colleague @bnamd87 rdcu.be/dG8Lq

Additionally, in a study led by @VasuLabUCSF & @LabRaleigh, researchers demonstrate how NF-1 mutant Schwann cell tumors undergo malignant transformation, identifying new potential strategies against treatment resistance: nature.com/articles/s41467-0… @UCSFCancer #neurofibromatosis

New featured image on our homepage! nature.com/ncomms/ 3 papers on schwannomas, tumors of the nervous system derived from Schwann cells @VasuLabUCSF @LabRaleigh @sjohnliu #CancerResearch @NatResCancer nature.com/articles/s41467-0… nature.com/articles/s41467-0… nature.com/articles/s41467-0…

Very proud of @LexiHaugh for her analysis of targeted DNA sequencing in cutaneous melanoma: biorxiv.org/content/10.1101/… @ad1600

Delighted to share that our work looking at functional interactions between neurofibromatosis tumor suppressors is officially accepted: rdcu.be/dvPyh

Looking forward to #SNO2023 presentation by #FrancisSCollinsScholar @VasuLabUCSF presenting innovative approaches to targeting NF1 loss in nervous system tumors @NeuroOnc @NTAPresearch @HopkinsMedicine #NF